In recent trading session, Cyclerion Therapeutics Inc (NASDAQ:CYCN) saw 44.63 million shares changing hands at last check today with its beta currently measuring 1.69. Company’s recent per share price level of $3.97 trading at $1.43 or 56.30% at last check today assigns it a market valuation of $10.75M. That most recent trading price of CYCN’s stock is at a discount of -138.54% from its 52-week high price of $9.47 and is indicating a premium of 68.01% from its 52-week low price of $1.27. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 33350.0 shares which gives us an average trading volume of 3.25 million if we extend that period to 3-months.

Cyclerion Therapeutics Inc (NASDAQ:CYCN) trade information

Upright in the green today for gaining 56.30%, in the last five days CYCN remained trading in the green while hitting it’s week-highest on Friday, 01/31/25 when the stock touched $3.97 price level, adding 11.19% to its value on the day. Cyclerion Therapeutics Inc’s shares saw a change of 23.29% in year-to-date performance and have moved 48.13% in past 5-day. Cyclerion Therapeutics Inc (NASDAQ:CYCN) showed a performance of 15.07% in past 30-days. Number of shares sold short was 14439.0 shares which calculate 0.78 days to cover the short interests.

Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s Major holders

Insiders are in possession of 21.90% of company’s total shares while institution are holding 40.41 percent of that, with stock having share float percentage of 51.74%. Investors also watch the number of corporate investors in a company very closely, which is 40.41% institutions for Cyclerion Therapeutics Inc that are currently holding shares of the company.

On the other hand, Vanguard Extended Market Index Fund and Fidelity Growth Company Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024, the former fund manager was holding 23.49 shares of worth $89261.0 or 0.87% of the total outstanding shares. The later fund manager was in possession of 20.56 shares on Oct 31, 2024, making its stake of worth around $78143.0 in the company or a holder of 0.76% of company’s stock.